img

Global Genetic Engineering Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Genetic Engineering Drug Market Insights, Forecast to 2034

Genetic Engineering Drug is also called Genetic Engineering or Genetic manipulation, and is the direct manipulation of an organism's genes using the Drug required in biotechnology.
Global Genetic Engineering Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Genetic Engineering Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Genetic Engineering Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Genetic Engineering Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Shanghai Lansheng Guojian Pharmaceutical
Biotech Pharmaceutical
Anhui Anke Biotechnology
GeneScience Pharmaceuticals
Beijing SL Pharmaceutical
Jiangsu Sihuan Bioengineering
Shenzhen Neptunus Interlong Bio-Technique
3SBio
Tonghua Dongbao Pharmaceutical
Segment by Type
Monoclonal Antibody
Recombinant Human Erythropoietin
Recombinant Human Interferon
Recombinant Human Growth Hormone
Recombinant Human Insulin

Segment by Application


Medicine
Research
Industrial
Agriculture
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Genetic Engineering Drug plant distribution, commercial date of Genetic Engineering Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Genetic Engineering Drug introduction, etc. Genetic Engineering Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Genetic Engineering Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Genetic Engineering Drug Product Introduction
1.2 Market by Type
1.2.1 Global Genetic Engineering Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibody
1.2.3 Recombinant Human Erythropoietin
1.2.4 Recombinant Human Interferon
1.2.5 Recombinant Human Growth Hormone
1.2.6 Recombinant Human Insulin
1.3 Market by Application
1.3.1 Global Genetic Engineering Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Medicine
1.3.3 Research
1.3.4 Industrial
1.3.5 Agriculture
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Genetic Engineering Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Genetic Engineering Drug Revenue by Region
2.2.1 Global Genetic Engineering Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Genetic Engineering Drug Revenue by Region (2018-2024)
2.2.3 Global Genetic Engineering Drug Revenue by Region (2024-2029)
2.2.4 Global Genetic Engineering Drug Revenue Market Share by Region (2018-2029)
2.3 Global Genetic Engineering Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Genetic Engineering Drug Sales by Region
2.4.1 Global Genetic Engineering Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Genetic Engineering Drug Sales by Region (2018-2024)
2.4.3 Global Genetic Engineering Drug Sales by Region (2024-2029)
2.4.4 Global Genetic Engineering Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Genetic Engineering Drug Sales by Manufacturers
3.1.1 Global Genetic Engineering Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Genetic Engineering Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Genetic Engineering Drug in 2022
3.2 Global Genetic Engineering Drug Revenue by Manufacturers
3.2.1 Global Genetic Engineering Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Genetic Engineering Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Genetic Engineering Drug Revenue in 2022
3.3 Global Key Players of Genetic Engineering Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Genetic Engineering Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Genetic Engineering Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Genetic Engineering Drug, Product Offered and Application
3.8 Global Key Manufacturers of Genetic Engineering Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Genetic Engineering Drug Sales by Type
4.1.1 Global Genetic Engineering Drug Historical Sales by Type (2018-2024)
4.1.2 Global Genetic Engineering Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Genetic Engineering Drug Sales Market Share by Type (2018-2029)
4.2 Global Genetic Engineering Drug Revenue by Type
4.2.1 Global Genetic Engineering Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Genetic Engineering Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Genetic Engineering Drug Revenue Market Share by Type (2018-2029)
4.3 Global Genetic Engineering Drug Price by Type
4.3.1 Global Genetic Engineering Drug Price by Type (2018-2024)
4.3.2 Global Genetic Engineering Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Genetic Engineering Drug Sales by Application
5.1.1 Global Genetic Engineering Drug Historical Sales by Application (2018-2024)
5.1.2 Global Genetic Engineering Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Genetic Engineering Drug Sales Market Share by Application (2018-2029)
5.2 Global Genetic Engineering Drug Revenue by Application
5.2.1 Global Genetic Engineering Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Genetic Engineering Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Genetic Engineering Drug Revenue Market Share by Application (2018-2029)
5.3 Global Genetic Engineering Drug Price by Application
5.3.1 Global Genetic Engineering Drug Price by Application (2018-2024)
5.3.2 Global Genetic Engineering Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Genetic Engineering Drug Market Size by Type
6.1.1 US & Canada Genetic Engineering Drug Sales by Type (2018-2029)
6.1.2 US & Canada Genetic Engineering Drug Revenue by Type (2018-2029)
6.2 US & Canada Genetic Engineering Drug Market Size by Application
6.2.1 US & Canada Genetic Engineering Drug Sales by Application (2018-2029)
6.2.2 US & Canada Genetic Engineering Drug Revenue by Application (2018-2029)
6.3 US & Canada Genetic Engineering Drug Market Size by Country
6.3.1 US & Canada Genetic Engineering Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Genetic Engineering Drug Sales by Country (2018-2029)
6.3.3 US & Canada Genetic Engineering Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Genetic Engineering Drug Market Size by Type
7.1.1 Europe Genetic Engineering Drug Sales by Type (2018-2029)
7.1.2 Europe Genetic Engineering Drug Revenue by Type (2018-2029)
7.2 Europe Genetic Engineering Drug Market Size by Application
7.2.1 Europe Genetic Engineering Drug Sales by Application (2018-2029)
7.2.2 Europe Genetic Engineering Drug Revenue by Application (2018-2029)
7.3 Europe Genetic Engineering Drug Market Size by Country
7.3.1 Europe Genetic Engineering Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Genetic Engineering Drug Sales by Country (2018-2029)
7.3.3 Europe Genetic Engineering Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Genetic Engineering Drug Market Size
8.1.1 China Genetic Engineering Drug Sales (2018-2029)
8.1.2 China Genetic Engineering Drug Revenue (2018-2029)
8.2 China Genetic Engineering Drug Market Size by Application
8.2.1 China Genetic Engineering Drug Sales by Application (2018-2029)
8.2.2 China Genetic Engineering Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Genetic Engineering Drug Market Size by Type
9.1.1 Asia Genetic Engineering Drug Sales by Type (2018-2029)
9.1.2 Asia Genetic Engineering Drug Revenue by Type (2018-2029)
9.2 Asia Genetic Engineering Drug Market Size by Application
9.2.1 Asia Genetic Engineering Drug Sales by Application (2018-2029)
9.2.2 Asia Genetic Engineering Drug Revenue by Application (2018-2029)
9.3 Asia Genetic Engineering Drug Sales by Region
9.3.1 Asia Genetic Engineering Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Genetic Engineering Drug Revenue by Region (2018-2029)
9.3.3 Asia Genetic Engineering Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Genetic Engineering Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Genetic Engineering Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Genetic Engineering Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Genetic Engineering Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Genetic Engineering Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Genetic Engineering Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Shanghai Lansheng Guojian Pharmaceutical
11.1.1 Shanghai Lansheng Guojian Pharmaceutical Company Information
11.1.2 Shanghai Lansheng Guojian Pharmaceutical Overview
11.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments
11.2 Biotech Pharmaceutical
11.2.1 Biotech Pharmaceutical Company Information
11.2.2 Biotech Pharmaceutical Overview
11.2.3 Biotech Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Biotech Pharmaceutical Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biotech Pharmaceutical Recent Developments
11.3 Anhui Anke Biotechnology
11.3.1 Anhui Anke Biotechnology Company Information
11.3.2 Anhui Anke Biotechnology Overview
11.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Anhui Anke Biotechnology Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Anhui Anke Biotechnology Recent Developments
11.4 GeneScience Pharmaceuticals
11.4.1 GeneScience Pharmaceuticals Company Information
11.4.2 GeneScience Pharmaceuticals Overview
11.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 GeneScience Pharmaceuticals Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GeneScience Pharmaceuticals Recent Developments
11.5 Beijing SL Pharmaceutical
11.5.1 Beijing SL Pharmaceutical Company Information
11.5.2 Beijing SL Pharmaceutical Overview
11.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Beijing SL Pharmaceutical Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Beijing SL Pharmaceutical Recent Developments
11.6 Jiangsu Sihuan Bioengineering
11.6.1 Jiangsu Sihuan Bioengineering Company Information
11.6.2 Jiangsu Sihuan Bioengineering Overview
11.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Jiangsu Sihuan Bioengineering Recent Developments
11.7 Shenzhen Neptunus Interlong Bio-Technique
11.7.1 Shenzhen Neptunus Interlong Bio-Technique Company Information
11.7.2 Shenzhen Neptunus Interlong Bio-Technique Overview
11.7.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments
11.8 3SBio
11.8.1 3SBio Company Information
11.8.2 3SBio Overview
11.8.3 3SBio Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 3SBio Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 3SBio Recent Developments
11.9 Tonghua Dongbao Pharmaceutical
11.9.1 Tonghua Dongbao Pharmaceutical Company Information
11.9.2 Tonghua Dongbao Pharmaceutical Overview
11.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Tonghua Dongbao Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Genetic Engineering Drug Industry Chain Analysis
12.2 Genetic Engineering Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Genetic Engineering Drug Production Mode & Process
12.4 Genetic Engineering Drug Sales and Marketing
12.4.1 Genetic Engineering Drug Sales Channels
12.4.2 Genetic Engineering Drug Distributors
12.5 Genetic Engineering Drug Customers
13 Market Dynamics
13.1 Genetic Engineering Drug Industry Trends
13.2 Genetic Engineering Drug Market Drivers
13.3 Genetic Engineering Drug Market Challenges
13.4 Genetic Engineering Drug Market Restraints
14 Key Findings in The Global Genetic Engineering Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Genetic Engineering Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibody
Table 3. Major Manufacturers of Recombinant Human Erythropoietin
Table 4. Major Manufacturers of Recombinant Human Interferon
Table 5. Major Manufacturers of Recombinant Human Growth Hormone
Table 6. Major Manufacturers of Recombinant Human Insulin
Table 7. Global Genetic Engineering Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Genetic Engineering Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Genetic Engineering Drug Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Genetic Engineering Drug Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Genetic Engineering Drug Revenue Market Share by Region (2018-2024)
Table 12. Global Genetic Engineering Drug Revenue Market Share by Region (2024-2029)
Table 13. Global Genetic Engineering Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Genetic Engineering Drug Sales by Region (2018-2024) & (K Units)
Table 15. Global Genetic Engineering Drug Sales by Region (2024-2029) & (K Units)
Table 16. Global Genetic Engineering Drug Sales Market Share by Region (2018-2024)
Table 17. Global Genetic Engineering Drug Sales Market Share by Region (2024-2029)
Table 18. Global Genetic Engineering Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global Genetic Engineering Drug Sales Share by Manufacturers (2018-2024)
Table 20. Global Genetic Engineering Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Genetic Engineering Drug Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Genetic Engineering Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Genetic Engineering Drug Price by Manufacturers 2018-2024 (USD/Unit)
Table 24. Global Genetic Engineering Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Genetic Engineering Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Engineering Drug as of 2022)
Table 26. Global Key Manufacturers of Genetic Engineering Drug, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Genetic Engineering Drug, Product Offered and Application
Table 28. Global Key Manufacturers of Genetic Engineering Drug, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Genetic Engineering Drug Sales by Type (2018-2024) & (K Units)
Table 31. Global Genetic Engineering Drug Sales by Type (2024-2029) & (K Units)
Table 32. Global Genetic Engineering Drug Sales Share by Type (2018-2024)
Table 33. Global Genetic Engineering Drug Sales Share by Type (2024-2029)
Table 34. Global Genetic Engineering Drug Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Genetic Engineering Drug Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Genetic Engineering Drug Revenue Share by Type (2018-2024)
Table 37. Global Genetic Engineering Drug Revenue Share by Type (2024-2029)
Table 38. Genetic Engineering Drug Price by Type (2018-2024) & (USD/Unit)
Table 39. Global Genetic Engineering Drug Price Forecast by Type (2024-2029) & (USD/Unit)
Table 40. Global Genetic Engineering Drug Sales by Application (2018-2024) & (K Units)
Table 41. Global Genetic Engineering Drug Sales by Application (2024-2029) & (K Units)
Table 42. Global Genetic Engineering Drug Sales Share by Application (2018-2024)
Table 43. Global Genetic Engineering Drug Sales Share by Application (2024-2029)
Table 44. Global Genetic Engineering Drug Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Genetic Engineering Drug Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Genetic Engineering Drug Revenue Share by Application (2018-2024)
Table 47. Global Genetic Engineering Drug Revenue Share by Application (2024-2029)
Table 48. Genetic Engineering Drug Price by Application (2018-2024) & (USD/Unit)
Table 49. Global Genetic Engineering Drug Price Forecast by Application (2024-2029) & (USD/Unit)
Table 50. US & Canada Genetic Engineering Drug Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada Genetic Engineering Drug Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Genetic Engineering Drug Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Genetic Engineering Drug Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Genetic Engineering Drug Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada Genetic Engineering Drug Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Genetic Engineering Drug Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Genetic Engineering Drug Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Genetic Engineering Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Genetic Engineering Drug Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Genetic Engineering Drug Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Genetic Engineering Drug Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada Genetic Engineering Drug Sales by Country (2024-2029) & (K Units)
Table 63. Europe Genetic Engineering Drug Sales by Type (2018-2024) & (K Units)
Table 64. Europe Genetic Engineering Drug Sales by Type (2024-2029) & (K Units)
Table 65. Europe Genetic Engineering Drug Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Genetic Engineering Drug Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Genetic Engineering Drug Sales by Application (2018-2024) & (K Units)
Table 68. Europe Genetic Engineering Drug Sales by Application (2024-2029) & (K Units)
Table 69. Europe Genetic Engineering Drug Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Genetic Engineering Drug Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Genetic Engineering Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Genetic Engineering Drug Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Genetic Engineering Drug Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Genetic Engineering Drug Sales by Country (2018-2024) & (K Units)
Table 75. Europe Genetic Engineering Drug Sales by Country (2024-2029) & (K Units)
Table 76. China Genetic Engineering Drug Sales by Type (2018-2024) & (K Units)
Table 77. China Genetic Engineering Drug Sales by Type (2024-2029) & (K Units)
Table 78. China Genetic Engineering Drug Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Genetic Engineering Drug Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Genetic Engineering Drug Sales by Application (2018-2024) & (K Units)
Table 81. China Genetic Engineering Drug Sales by Application (2024-2029) & (K Units)
Table 82. China Genetic Engineering Drug Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Genetic Engineering Drug Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Genetic Engineering Drug Sales by Type (2018-2024) & (K Units)
Table 85. Asia Genetic Engineering Drug Sales by Type (2024-2029) & (K Units)
Table 86. Asia Genetic Engineering Drug Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Genetic Engineering Drug Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Genetic Engineering Drug Sales by Application (2018-2024) & (K Units)
Table 89. Asia Genetic Engineering Drug Sales by Application (2024-2029) & (K Units)
Table 90. Asia Genetic Engineering Drug Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Genetic Engineering Drug Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Genetic Engineering Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Genetic Engineering Drug Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Genetic Engineering Drug Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Genetic Engineering Drug Sales by Region (2018-2024) & (K Units)
Table 96. Asia Genetic Engineering Drug Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Genetic Engineering Drug Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Genetic Engineering Drug Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Genetic Engineering Drug Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Genetic Engineering Drug Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Genetic Engineering Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Genetic Engineering Drug Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Genetic Engineering Drug Sales by Country (2024-2029) & (K Units)
Table 110. Shanghai Lansheng Guojian Pharmaceutical Company Information
Table 111. Shanghai Lansheng Guojian Pharmaceutical Description and Major Businesses
Table 112. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Shanghai Lansheng Guojian Pharmaceutical Recent Developments
Table 115. Biotech Pharmaceutical Company Information
Table 116. Biotech Pharmaceutical Description and Major Businesses
Table 117. Biotech Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Biotech Pharmaceutical Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Biotech Pharmaceutical Recent Developments
Table 120. Anhui Anke Biotechnology Company Information
Table 121. Anhui Anke Biotechnology Description and Major Businesses
Table 122. Anhui Anke Biotechnology Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Anhui Anke Biotechnology Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Anhui Anke Biotechnology Recent Developments
Table 125. GeneScience Pharmaceuticals Company Information
Table 126. GeneScience Pharmaceuticals Description and Major Businesses
Table 127. GeneScience Pharmaceuticals Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. GeneScience Pharmaceuticals Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. GeneScience Pharmaceuticals Recent Developments
Table 130. Beijing SL Pharmaceutical Company Information
Table 131. Beijing SL Pharmaceutical Description and Major Businesses
Table 132. Beijing SL Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Beijing SL Pharmaceutical Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Beijing SL Pharmaceutical Recent Developments
Table 135. Jiangsu Sihuan Bioengineering Company Information
Table 136. Jiangsu Sihuan Bioengineering Description and Major Businesses
Table 137. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Jiangsu Sihuan Bioengineering Recent Developments
Table 140. Shenzhen Neptunus Interlong Bio-Technique Company Information
Table 141. Shenzhen Neptunus Interlong Bio-Technique Description and Major Businesses
Table 142. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Shenzhen Neptunus Interlong Bio-Technique Recent Developments
Table 145. 3SBio Company Information
Table 146. 3SBio Description and Major Businesses
Table 147. 3SBio Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. 3SBio Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. 3SBio Recent Developments
Table 150. Tonghua Dongbao Pharmaceutical Company Information
Table 151. Tonghua Dongbao Pharmaceutical Description and Major Businesses
Table 152. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 153. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Tonghua Dongbao Pharmaceutical Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Genetic Engineering Drug Distributors List
Table 158. Genetic Engineering Drug Customers List
Table 159. Genetic Engineering Drug Market Trends
Table 160. Genetic Engineering Drug Market Drivers
Table 161. Genetic Engineering Drug Market Challenges
Table 162. Genetic Engineering Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Genetic Engineering Drug Product Picture
Figure 2. Global Genetic Engineering Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Genetic Engineering Drug Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Recombinant Human Erythropoietin Product Picture
Figure 6. Recombinant Human Interferon Product Picture
Figure 7. Recombinant Human Growth Hormone Product Picture
Figure 8. Recombinant Human Insulin Product Picture
Figure 9. Global Genetic Engineering Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Genetic Engineering Drug Market Share by Application in 2022 & 2029
Figure 11. Medicine
Figure 12. Research
Figure 13. Industrial
Figure 14. Agriculture
Figure 15. Other
Figure 16. Genetic Engineering Drug Report Years Considered
Figure 17. Global Genetic Engineering Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Genetic Engineering Drug Revenue 2018-2029 (US$ Million)
Figure 19. Global Genetic Engineering Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 20. Global Genetic Engineering Drug Revenue Market Share by Region (2018-2029)
Figure 21. Global Genetic Engineering Drug Sales 2018-2029 ((K Units)
Figure 22. Global Genetic Engineering Drug Sales Market Share by Region (2018-2029)
Figure 23. US & Canada Genetic Engineering Drug Sales YoY (2018-2029) & (K Units)
Figure 24. US & Canada Genetic Engineering Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Europe Genetic Engineering Drug Sales YoY (2018-2029) & (K Units)
Figure 26. Europe Genetic Engineering Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 27. China Genetic Engineering Drug Sales YoY (2018-2029) & (K Units)
Figure 28. China Genetic Engineering Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Asia (excluding China) Genetic Engineering Drug Sales YoY (2018-2029) & (K Units)
Figure 30. Asia (excluding China) Genetic Engineering Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Genetic Engineering Drug Sales YoY (2018-2029) & (K Units)
Figure 32. Middle East, Africa and Latin America Genetic Engineering Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 33. The Genetic Engineering Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 34. The Top 5 and 10 Largest Manufacturers of Genetic Engineering Drug in the World: Market Share by Genetic Engineering Drug Revenue in 2022
Figure 35. Global Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Global Genetic Engineering Drug Sales Market Share by Type (2018-2029)
Figure 37. Global Genetic Engineering Drug Revenue Market Share by Type (2018-2029)
Figure 38. Global Genetic Engineering Drug Sales Market Share by Application (2018-2029)
Figure 39. Global Genetic Engineering Drug Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Genetic Engineering Drug Sales Market Share by Type (2018-2029)
Figure 41. US & Canada Genetic Engineering Drug Revenue Market Share by Type (2018-2029)
Figure 42. US & Canada Genetic Engineering Drug Sales Market Share by Application (2018-2029)
Figure 43. US & Canada Genetic Engineering Drug Revenue Market Share by Application (2018-2029)
Figure 44. US & Canada Genetic Engineering Drug Revenue Share by Country (2018-2029)
Figure 45. US & Canada Genetic Engineering Drug Sales Share by Country (2018-2029)
Figure 46. U.S. Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 47. Canada Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 48. Europe Genetic Engineering Drug Sales Market Share by Type (2018-2029)
Figure 49. Europe Genetic Engineering Drug Revenue Market Share by Type (2018-2029)
Figure 50. Europe Genetic Engineering Drug Sales Market Share by Application (2018-2029)
Figure 51. Europe Genetic Engineering Drug Revenue Market Share by Application (2018-2029)
Figure 52. Europe Genetic Engineering Drug Revenue Share by Country (2018-2029)
Figure 53. Europe Genetic Engineering Drug Sales Share by Country (2018-2029)
Figure 54. Germany Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 55. France Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 56. U.K. Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 57. Italy Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 58. Russia Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 59. China Genetic Engineering Drug Sales Market Share by Type (2018-2029)
Figure 60. China Genetic Engineering Drug Revenue Market Share by Type (2018-2029)
Figure 61. China Genetic Engineering Drug Sales Market Share by Application (2018-2029)
Figure 62. China Genetic Engineering Drug Revenue Market Share by Application (2018-2029)
Figure 63. Asia Genetic Engineering Drug Sales Market Share by Type (2018-2029)
Figure 64. Asia Genetic Engineering Drug Revenue Market Share by Type (2018-2029)
Figure 65. Asia Genetic Engineering Drug Sales Market Share by Application (2018-2029)
Figure 66. Asia Genetic Engineering Drug Revenue Market Share by Application (2018-2029)
Figure 67. Asia Genetic Engineering Drug Revenue Share by Region (2018-2029)
Figure 68. Asia Genetic Engineering Drug Sales Share by Region (2018-2029)
Figure 69. Japan Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 70. South Korea Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 71. China Taiwan Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 72. Southeast Asia Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 73. India Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Genetic Engineering Drug Sales Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Genetic Engineering Drug Revenue Market Share by Type (2018-2029)
Figure 76. Middle East, Africa and Latin America Genetic Engineering Drug Sales Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Genetic Engineering Drug Revenue Market Share by Application (2018-2029)
Figure 78. Middle East, Africa and Latin America Genetic Engineering Drug Revenue Share by Country (2018-2029)
Figure 79. Middle East, Africa and Latin America Genetic Engineering Drug Sales Share by Country (2018-2029)
Figure 80. Brazil Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 81. Mexico Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 82. Turkey Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 83. Israel Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 84. GCC Countries Genetic Engineering Drug Revenue (2018-2029) & (US$ Million)
Figure 85. Genetic Engineering Drug Value Chain
Figure 86. Genetic Engineering Drug Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries